CS logo
small CS logo
Rowe Neurology Institute

Lenexa, Kansas, United States
Neurologist in Lenexa, Kansas
8550 Marshall Dr #100, Lenexa, KS 66214

About Rowe Neurology Institute


"The right diagnosis can be life changing- The Rowe Neurology Institute provides caring individualized comprehensive diagnosis and treatment for patients with neurological diseases. We also provide patients with an opportunity to participate in FDA supervised clinical trials in MS, Alzheimer's Disease, Headache, and Sleep Disorders, -disorders for which no cause has been found and no cure is known. We are an independent, free standing Institute, and provide cost effective care for patients with high deductibles. We are out of network, and are independent from all hospital systems and insurance plans, but can work with all of them."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Allergan
3
AbbVie
1
Balance Therapeutics
1
Cefaly Technology
1
Eli Lilly and Company
1
Idorsia Pharmaceuticals Ltd.
1
MedDay Pharmaceuticals SA
1
Total Rows: 7

Clinical Trials at Rowe Neurology Institute


During the past decade, Rowe Neurology Institute conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years660033000022Started TrialsCompleted Trails20162017201802468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Acute Treatment of Migraine With e-TNS
2016-02-01
2017-03-31
Completed
106
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
2016-10-18
2018-04-20
Completed
20
Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine
2016-07-22
2017-12-14
Completed
1,672
Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention
2016-09-06
2018-04-23
Completed
834
An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine
2016-09-13
2018-08-02
Completed
1,254
Effect of MD1003 in Progressive Multiple Sclerosis (SPI2)
2016-12-01
2020-04-23
Terminated
642
A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease
2018-04-30
2021-10-25
Completed
360
A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia
2018-05-29
2020-05-28
Unknown status
80

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Rowe Neurology Institute" #1 sponsor was "Allergan" with 3 trials, followed by "AbbVie" with 1 trials sponsored, "Balance Therapeutics" with 1 trials sponsored, "Cefaly Technology" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
Created with Highcharts 11.1.0Top Leading SponsorsAllergan: 3Allergan: 3AbbVie: 1AbbVie: 1Balance Therapeutics: 1Balance Therapeutics: 1Cefaly Technology: 1Cefaly Technology: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Idorsia Pharmaceuticals Ltd.: 1Idorsia Pharmaceuticals Ltd.: 1MedDay Pharmaceuticals SA: 1MedDay Pharmaceuticals SA: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Rowe Neurology Institute


According to Clinical.Site data, the most researched conditions in "Rowe Neurology Institute" are "Migraine, With or Without Aura" (3 trials), "Multiple Sclerosis" (2 trials), "Alzheimer Disease (AD)" (1 trials), "Idiopathic Hypersomnia" (1 trials) and "Insomnia Disorder" (1 trials). Many other conditions were trialed in "Rowe Neurology Institute" in a lesser frequency.

Clinical Trials Intervention Types at Rowe Neurology Institute


Most popular intervention types in "Rowe Neurology Institute" are "Drug" (8 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Placebo-matching Ubrogepant" (2 trials), "Ubrogepant" (2 trials), "ABT-555" (1 trials) and "Atogepant" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Rowe Neurology Institute


The vast majority of trials in "Rowe Neurology Institute" are 9 trials for "All" genders.

Clinical Trials Status at Rowe Neurology Institute


Currently, there are NaN active trials in "Rowe Neurology Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Rowe Neurology Institute, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Rowe Neurology Institute, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Phase 2: 3Phase 2: 3Not Applicable: 1Not Applicable: 1Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Terminated: 1Terminated: 1Unknown status: 1Unknown status: 1

Departments of Rowe Neurology Institute


Rowe Neurology Institute has several departments that took part in Clinical trials: "Rowe Neurology Institute RNI - Lenexa" - 2 trials
Departments List
Total Rows: 1